AI assistant
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2011
Oct 11, 2011
29977_dirs_2011-10-11_bd04aea4-4b55-46bf-aaf8-f7baece2d744.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2011-10-10
Reporting Person: Terifay Robert J (SVP Commercial)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-10 | Common Stock | M | 20000 | $21.34 | Acquired | 20000 | Direct |
| 2011-10-10 | Common Stock | F | 6588 | $64.78 | Disposed | 13412 | Direct |
| 2011-10-10 | Common Stock | F | 6198 | $64.78 | Disposed | 7214 | Direct |
| 2011-10-10 | Common Stock | M | 9372 | $21.34 | Acquired | 16586 | Direct |
| 2011-10-11 | Common Stock | S | 402 | $64.98 | Disposed | 16184 | Direct |
| 2011-10-11 | Common Stock | S | 6812 | $65.34 | Disposed | 9372 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-10 | Incentive Stock Option (right to buy) | $21.34 | M | 9372 | Disposed | 2017-02-26 | Common Stock (9372) | Direct |
| 2011-10-10 | Non-Qualified Stock Option (right to buy) | $21.34 | M | 20000 | Disposed | 2017-02-26 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1387 | Indirect |
Footnotes
F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2: Represents volume-weighted average price of sales of 402 shares of Company stock on October 11, 2011 at prices ranging from $64.97 to $64.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on October 11, 2011 at each separate price.
F3: Represents volume-weighted average price of sales of 6,812 shares of Company stock on October 11, 2011 at prices ranging from $65.06 to $65.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on October 11, 2011 at each separate price.
F4: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
F5: Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.